Details of the Drug

General Information of Drug (ID: DM2CKIJ)

Drug Name
Efanesoctocog alfa
Synonyms BIVV001; Altuviiio
Indication
Disease Entry ICD 11 Status REF
Haemophilia A 3B10.0 Approved [1]
Affected Organisms
Humans and other mammals
Drug Type
Protein
Cross-matching ID
UNII
WH7BHQ0RB4
DrugBank ID
DB16662
TTD ID
DMU9P2

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Coagulation factor VIII (F8) TT1290U FA8_HUMAN Replacement [2]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

Molecular Expression Atlas of This Drug

The Studied Disease Haemophilia A
ICD Disease Classification 3B10.0
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Coagulation factor VIII (F8) DTT F8 1.08E-22 0.89 1.82
Molecular Expression Atlas (MEA) Jump to Detail Molecular Expression Atlas of This Drug

References

1 Clinical pipeline report, company report or official report of Sanofi
2 Efanesoctocog alfa for hemophilia A: results from a phase 1 repeat-dose study. Blood Adv. 2022 Feb 22;6(4):1089-1094.